Publications
2023
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Houten, R., Fleeman, N., Mahon, J., Chaplin, M., Edwards, K., Beale, S., . . . Palmieri, C. (2023). Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN. doi:10.1007/s41669-023-00405-2
2015
Eribulin for the Treatment of Advanced or Metastatic Breast Cancer: A NICE Single Technology Appraisal
Greenhalgh, J., Bagust, A., Boland, A., Oyee, J., Trevor, N., Beale, S., . . . O'Reilly, S. (2015). Eribulin for the Treatment of Advanced or Metastatic Breast Cancer: A NICE Single Technology Appraisal. PharmacoEconomics, 33(2), 137-148. doi:10.1007/s40273-014-0214-2
2013
Description of health problem
Brown, T., Pilkington, G., Bagust, A., Boland, A., Oyee, J., Smith, C. T., . . . Dickson, R. (2013). Description of health problem. HEALTH TECHNOLOGY ASSESSMENT, 17(31), 1-+. doi:10.3310/hta17310
Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review
Brown, T., Pilkington, G., Boland, A., Oyee, J., Smith, C. T., Dundar, Y., . . . Dickson, R. (2013). Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review. HEALTH TECHNOLOGY ASSESSMENT, 17(6), 1-+. doi:10.3310/hta17060
Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin's Lymphoma A NICE Single Technology Appraisal
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Oyee, J., Beale, S., . . . Chu, P. (2013). Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin's Lymphoma A NICE Single Technology Appraisal. PHARMACOECONOMICS, 31(5), 403-413. doi:10.1007/s40273-013-0043-8
SHORT-TERM MANAGEMENT OF AGITATION ASSOCIATED WITH PSYCHOTIC OR BIPOLAR DISORDERS: A SYSTEMATIC REVIEW
Dundar, Y., & Greenhalgh, J. (2013). SHORT-TERM MANAGEMENT OF AGITATION ASSOCIATED WITH PSYCHOTIC OR BIPOLAR DISORDERS: A SYSTEMATIC REVIEW. In EUROPEAN PSYCHIATRY Vol. 28. Retrieved from https://www.webofscience.com/
Short term managment of agitation associated with psychotic or bipolar disorders: a systematic review
Dundar, Y., Dwan, K., & Greenhalgh, J. (2013). Short term managment of agitation associated with psychotic or bipolar disorders: a systematic review. In European Congress of Psychiatry (pp. 1). Nice: EPA.
2012
The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation
Cherry, M. G., Greenhalgh, J., Osipenko, L., Venkatachalam, M., Boland, A., Dundar, Y., . . . Rees, D. C. (2012). The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 16(43), 1-+. Retrieved from https://www.webofscience.com/
A systematic review of prevention and intervention strategies for populations at high risk of engaging in violent behaviour: update 2002-8
Hockenhull, J. C., Whittington, R., Leitner, M., Barr, W., McGuire, J., Cherry, M. G., . . . Dickson, R. (2012). A systematic review of prevention and intervention strategies for populations at high risk of engaging in violent behaviour: update 2002-8. HEALTH TECHNOLOGY ASSESSMENT, 16(3), 1-+. doi:10.3310/hta16030
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy
Hockenhull, J., Elremeli, M., Cherry, M. G., Mahon, J., Lai, M., Darroch, J., . . . Boyle, R. (2012). A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy. HEALTH TECHNOLOGY ASSESSMENT, 16(12), 1-+. doi:10.3310/hta16120
2011
Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy A NICE Single Technology Appraisal
Dickson, R., Bagust, A., Boland, A., Blundell, M., Davis, H., Dundar, Y., . . . Ramani, V. S. (2011). Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy A NICE Single Technology Appraisal. PHARMACOECONOMICS, 29(12), 1051-1062. doi:10.2165/11591600-000000000-00000
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis
Greenhalgh, J., Bagust, A., Boland, A., Saborido, C. M., Oyee, J., Blundell, M., . . . Fisher, M. (2011). Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. HEALTH TECHNOLOGY ASSESSMENT, 15(31), 1-+. doi:10.3310/hta15310
Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses
Fleeman, N., Dundar, Y., Dickson, R., Jorgensen, A., Pushpakom, S., McLeod, C., . . . Walley, T. (2011). Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses. PHARMACOGENOMICS JOURNAL, 11(1), 1-14. doi:10.1038/tpj.2010.73
Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer (NSCLC)
Dickson, R., Bagust, A., Boland, A., Blundell, M., Brown, T., Davis, H., . . . Ramani, V. (2011). Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer (NSCLC). Health Technology Assessment, in pre.
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis
Fleeman, N., Bagust, A., Boland, A., Dickson, R., Dundar, Y., Moonan, M., . . . Thorp, N. (2011). Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis. HEALTH TECHNOLOGY ASSESSMENT, 15(42), 1-+. doi:10.3310/hta15420
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma: A Single Technology Appraisal
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Oyee, J., Dundar, Y., . . . Chu, P. (2011). Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma: A Single Technology Appraisal.
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma: A Single Technology Appraisal
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Oyee, J., Dundar, Y., . . . Chu, P. (2011). Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma: A Single Technology Appraisal.
Ticagrelor for the treatment of acute coronary syndromes: A Single Technology Appraisal
Greenhalgh, J., Bagust, A., Boland, A., Blundell, M., Lai, M., Dundar, Y., . . . Fisher, M. (2011). Ticagrelor for the treatment of acute coronary syndromes: A Single Technology Appraisal.
2010
Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
Brown, T., Boland, A., Bagust, A., Oyee, J., Hockenhull, J., Dundar, Y., . . . Proudlove, C. (2010). Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. HEALTH TECHNOLOGY ASSESSMENT, 14, 71-79. doi:10.3310/hta14suppl2/10
Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck A NICE Single Technology Appraisal
Bagust, A., Greenhalgh, J., Boland, A., Fleeman, N., McLeod, C., Dickson, R., . . . Shaw, R. (2010). Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck A NICE Single Technology Appraisal. PHARMACOECONOMICS, 28(6), 439-448. doi:10.2165/11532220-000000000-00000
Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes
Greenhalgh, J., Hockenhull, J., Rao, N., Dundar, Y., Dickson, R. C., & Bagust, A. (2010). Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD004587.pub2
Abatacept for the treatment of rheumatoid arthritis
Hockenhull, J., Boland, A., Bagust, A., Dundar, Y., Fleeman, N., Kennedy, T., . . . Dickson, R. (2010). Abatacept for the treatment of rheumatoid arthritis. Health Technology Assessment. Retrieved from http://www.hta.ac.uk/project/1648.asp
Biofeedback for hypertension: a systematic review.
Greenhalgh, J., Dickson, R., & Dundar, Y. (2010). Biofeedback for hypertension: a systematic review.. Journal of hypertension, 28(4), 644-652. doi:10.1097/hjh.0b013e3283370e20
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
Fleeman, N., Bagust, A., McLeod, C., Greenhalgh, J., Boland, A., Dundar, Y., . . . Pearson, M. (2010). Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. HEALTH TECHNOLOGY ASSESSMENT, 14, 47-53. doi:10.3310/hta14suppl1/07
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
Greenhalgh, J., McLeod, C., Bagust, A., Boland, A., Fleeman, N., Dundar, Y., . . . Pearson, M. (2010). Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer. HEALTH TECHNOLOGY ASSESSMENT, 14, 33-39. doi:10.3310/hta14suppl2/05
Pemetrexed for the treatment of relapsed non-small cell lung cancer
Hockenhull, J., Boland, A., Bagust, A., Dundar, Y., Davis, H., Dickson, R., . . . Proudlove, N. (2010). Pemetrexed for the treatment of relapsed non-small cell lung cancer. Health Technology Assessment. Retrieved from http://www.hta.ac.uk/erg/reports/1641.pdf
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention
Greenhalgh, J., Bagust, A., Boland, A., Saborido, C. M., Fleeman, N., McLeod, C., . . . Fisher, M. (2010). Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention. HEALTH TECHNOLOGY ASSESSMENT, 14, 31-38. doi:10.3310/hta14suppl1/05
The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation
Fleeman, N., McLeod, C., Bagust, A., Beale, S., Boland, A., Dundar, Y., . . . Dickson, R. (2010). The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 14(3), 1-+. doi:10.3310/hta14030
2009
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma
Dundar, Y., Bagust, A., Hounsome, J., McLeod, C., Boland, A., Davis, H., . . . Dickson, R. (2009). Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma. HEALTH TECHNOLOGY ASSESSMENT, 13, 23-28. doi:10.3310/hta13suppl1/04
The effects of biofeedback for the treatment of essential hypertension: A systematic review
Greenhalgh, J., Dickson, R., & Dundar, Y. (2009). The effects of biofeedback for the treatment of essential hypertension: A systematic review. Health Technology Assessment, 13(46). doi:10.3310/hta13460
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation
McLeod, C., Fleeman, N., Kirkham, J., Bagust, A., Boland, A., Chu, P., . . . Walley, T. (2009). Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 13(1), 1-+. doi:10.3310/hta13010
Rituximab for the treatment of rheumatoid arthritis
Bagust, A., Boland, A., Hockenhull, J., Fleeman, N., Greenhalgh, J., Dundar, Y., . . . Dickson, R. (2009). Rituximab for the treatment of rheumatoid arthritis. HEALTH TECHNOLOGY ASSESSMENT, 13, 23-29. doi:10.3310/hta13suppl2/04
2008
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation: Abstract
Hockenhull, J. C., Dwan, K., Boland, A., Smith, G., Bagust, A., Duendar, Y., . . . Dickson, R. (2008). The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation: Abstract. HEALTH TECHNOLOGY ASSESSMENT, 12(12), 1-+. Retrieved from https://www.webofscience.com/
2007
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod, C., Bagust, A., Boland, A., Dagenais, P., Dickson, R., Dundar, Y., . . . Walley, T. (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 11(28), 1-iv. doi:10.3310/hta11280
Drug-eluting stents: a systematic review and economic evaluation.
Hill, R. A., Boland, A., Dickson, R., Dündar, Y., Haycox, A., McLeod, C., . . . Bagust, A. (2007). Drug-eluting stents: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 11(46), iii-221. doi:10.3310/hta11460
Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation
Dundar, Y., Bagust, A., Dickson, R., Dodd, S., Green, J., Haycox, A., . . . Walley, T. (2007). Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 11(1), 1-+. Retrieved from https://www.webofscience.com/
2006
Case study of the comparison of data from conference abstracts and full-text articles in health technology assessment of rapidly evolving technologies: Does it make a difference?
Dundar, Y., Dodd, S., Williamson, P., Dickson, R., & Walley, T. (2006). Case study of the comparison of data from conference abstracts and full-text articles in health technology assessment of rapidly evolving technologies: Does it make a difference?. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 22(3), 288-294. doi:10.1017/S0266462306051166
Searching for and use of conference abstracts in health technology assessments: Policy and practice
Dundar, Y., Dodd, S., Williamson, P., Walley, T., & Dickson, R. (2006). Searching for and use of conference abstracts in health technology assessments: Policy and practice. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 22(3), 283-287. doi:10.1017/S0266462306051154
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies
Dundar, Y., Dodd, S., Dickson, R., Walley, T., Haycox, A., & Williamson, P. R. (2006). Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. Health Technology Assessment, 10(5), 1-162. Retrieved from http://www.hta.ac.uk/project.asp?PjtId=1433
2005
Pemetrexed disodium for the treatment of malignant mesothelioma:systematic review
Dundar, Y., Haycox, A., & Green, J. A. (2005). Pemetrexed disodium for the treatment of malignant mesothelioma:systematic review. health Technology Assessment, 04/17, 95.
2004
Exploring groups at high risk of restenosis
Bagust, A., Bakhai, A., Dickson, R., Dundar, Y., Hill, R. A., & Walley, T. (2004). Exploring groups at high risk of restenosis. EUROPEAN HEART JOURNAL, 25(23), 2168-2169. doi:10.1016/j.ehj.2004.09.028
Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.
Dündar, Y., Dodd, S., Strobl, J., Boland, A., Dickson, R., & Walley, T. (2004). Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.. Human psychopharmacology, 19(5), 305-322. doi:10.1002/hup.594
Coronary artery stents:: a rapid systematic review and economic evaluation
Hill, R., Bagust, A., Bakhai, A., Dickson, R., Dündar, Y., Haycox, A., . . . Walley, T. (2004). Coronary artery stents:: a rapid systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 8(35), 1-+. Retrieved from https://www.webofscience.com/
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation
Dundar, Y., Boland, A., Strobl, J., Dodd, S., Haycox, A., Bagust, A., . . . Walley, T. (2004). Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technology Assessment, 8(24), 1-140.
Newer hypnotic drugs for the short-term management of insomnia:: a systematic review and economic evaluation
Dündar, Y., Boland, A., Strobl, J., Dodd, S., Haycox, A., Bagust, A., . . . Walley, T. (2004). Newer hypnotic drugs for the short-term management of insomnia:: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 8(24), 1-+. Retrieved from https://www.webofscience.com/
2003
Early thrombosis for the treatment of acute myocardial infarction: A systematic review and economic evaluation
Boland, A., Dundar, Y., Bagust, A., Haycox, A., Hill, R., Mujica Mota, R., . . . Dickson, R. (2003). Early thrombosis for the treatment of acute myocardial infarction: A systematic review and economic evaluation. Health Technology Assessment, 7(15).
Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.
Boland, A., Dundar, Y., Bagust, A., Haycox, A., Hill, R., Mujica Mota, R., . . . Dickson, R. (2003). Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 7(15), 1-136. doi:10.3310/hta7150